PRIMARY STUDY

Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders

Key Findings:  The reviewers conclude that cannabinoids, in particular CBD, improves symptoms associated with common co-morbidities in ASD's. In addition, cannabinoid-based therapeutics is associated with low adverse effects and a reduction in concomitant medication.